🇺🇸 FDA
Patent

US 10123979

Methods of treating developmental disorders with biguanides

granted A61KA61K31/155A61P

Quick answer

US patent 10123979 (Methods of treating developmental disorders with biguanides) held by OVID THERAPEUTICS INC. expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
OVID THERAPEUTICS INC.
Grant date
Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K31/155, A61P, A61P25/08, A61P25/14